hypertensive patients / A. F. Sanjuliani [et al.] // J. Clin. Basic Cardiol. – 2004. –
Vol. 7, № 1-4. – P.19-25.
169.
Effects of weight cycling on urinary catecholamines: sympathoadrenal role in
refeeding hypertension / P. Ernsberger [et al.] //
– 1998. – Vol. 16,
№ 12. – P. 2001-2005.
170.
Efficacy of moxonidine in the treatment of hypertension in obese,
noncontrolled hypertensive patients / J. Abellan [et al.] // Kidney Int. – 2005. –
Vol. 93. – P. 20-24.
171.
Efficacy of perindopril in reduction of cardiovascular events among patients
with stable coronary artery disease: randomised, doubleblind, placebo-controlled,
multicentre trial (the EUROPA study) / K. M.
et al.] // Lancet. – 2003. – Vol.
362, № 9386. – P. 782-788.
172.
Elevated blood pressure in relation to overweight and obesity among children
in a rural Canadian community / M. Salvadori [et al.] // Pediatrics. – 2008. – Vol.
122, № 4. – P. 821-827.
173.
Selective imidazoline receptor agonists and lipid metabolism / M. S.
Elisaf, A.
K.
/ Clin. Chem. Lab. Med. – 1999. – Vol. 37,
№ 2. – P. 165.
174.
Elliott W. Incident diabetes in clinical trials of antihypertensive drugs: a
network meta-analysis / W. Elliott, P. M. Meyer // Lancet. – 2007. – Vol. 369, №
9557. – P. 201-207
175.
Elliott W. J. Cardiovascular events in hypertension trials of angiotensin
converting-enzyme inhibitors / W. J. Elliott // J. Clin. Hypertens. (Greenwich). –
2005. – Vol. 7, № 8. – P. 2-4.
176.
Endothelial dysfunction hypertension / S. Taddei [et al.] // J. Nephrol. – 2000.
– Vol. 13. – P. 205-210.
177.
Endothelial dysfunction in arterial hypertension / F. Contreras [et al.] // J.
Human Hypertens. – 2000. – Vol. 14, № 1. – P. 20-25.
